Loading
PERDOCEO EDUCATION Corp Stock: price and insider trades · United States
PERDOCEO EDUCATION Corp: what insiders have been doing
PERDOCEO EDUCATION Corp, classified in the Healthcare & Pharma sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Between 18 October 2025 and 18 October 2026, 16 insiders published 34 filings.
Only sales appear on the open market, 8 sales in all totalling €6.2M, filed by 5 insiders. One trade stands out by size: a sale of €1.3M from Nelson Todd S, disclosed on 17 September 2026, or 0.076% of market capitalisation.
With 34 filings in twelve months, the company is more active than the median of 19 filings across the 5,811 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed no purchases and 67 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 846.1 m USD and net income at 159.9 m USD; the dividend was 0.56 USD per share.
Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Anixa Biosciences Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
231
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€25M
67 ops. · all time
Who traded when
BuySaleAshish R. Ghia5 sales
Todd S. Nelson5 sales
Elise Baskel3 sales
Greg E. Jansen3 sales
David C. Czeszewski2 sales
John Robert Kline2 sales
+6 other insiders
Analyst consensus: bullish or bearish?
Analysts rate PERDOCEO EDUCATION Corp Buy (bullish), based on 1 analysts. Average price target: US$44.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 964 of 24,158 companies
80.2
score / 100
Value76
Quality84
FCF yld10%
Earn yld7.6%
EV/EBITDA8.4x
ROE18%
Gross mgn77%
Net mgn19%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$33.55
Analyst consensus
1 analystsBuy
US$44.00Target US$44.00(+31%)US$44.00
Income statement
RevenueUS$846.1M
Gross profitUS$648.6M77% margin
EBITDAUS$264.9M31% margin
Net incomeUS$159.9M20.6% margin
Valuation
PER (trailing)12.2x
PER (forward)10.2x
P/Book2.0x
Beta0.72
Balance sheet & cash
Market capUS$2.1B
Total debtUS$118.3M
Free Cash FlowUS$216.7M
Debt / Equity11%
Profitability & ownership
ROE17.6%
ROA10.0%
% insiders1.2%
% institutions104.4%
Last declaration on 17 September 2026
Declarations231 total
46,199 shares@ US$32.890.076% mcap11.1% of flowCommon StockSEC:0001193125-26-394619:0
46,199 shares@ US$32.88990.076% mcap100.0% of flowCommonSEC144:0001950047-26-009516
11,271 shares@ US$9.690.0055% mcap14.3% of flowCommon StockSEC:0001193125-26-347276:0
11,271 shares@ US$31.780.018% mcap46.7% of flowCommon StockSEC:0001193125-26-347276:1
11,271 shares@ US$31.77870.018% mcap100.0% of flowCommonSEC144:0001950047-26-007939
13,511 shares@ US$31.59940.021% mcap100.0% of flowCommonSEC144:0001950047-26-007940
9,308 shares@ US$34.7892100.0% of flowCommonSEC144:0001950047-26-005670
3,987 shares0Common StockSEC:0001193125-26-239777:0
30,158 shares@ US$38.0040.6% of flowCommon StockSEC:0001193125-26-145840:0
40,000 shares@ US$35.2410.3% of flowCommon StockSEC:0001193125-26-124461:0
11,089 shares@ US$37.0010.2% of flowCommon StockSEC:0001193125-26-124460:0
11,090 shares@ US$35.079.8% of flowCommon StockSEC:0001193125-26-118001:0
2,060 shares@ US$35.780.0030% mcap2.6% of flowCommon StockSEC:0001193125-26-111325:0
839 shares@ US$35.780.0012% mcap6.1% of flowCommon StockSEC:0001193125-26-111320:0
1,223 shares@ US$35.780.0018% mcap2.5% of flowCommon StockSEC:0001193125-26-111326:0
792 shares@ US$35.780.0012% mcap2.5% of flowCommon StockSEC:0001193125-26-111329:0
591 shares@ US$35.7810.7% of flowCommon StockSEC:0001193125-26-111322:0
2,221 shares@ US$35.780.0032% mcap3.7% of flowCommon StockSEC:0001193125-26-111323:0
10,333 shares@ US$35.780.015% mcap2.7% of flowCommon StockSEC:0001193125-26-111331:0
3,288 shares@ US$35.780.0048% mcap3.0% of flowCommon StockSEC:0001193125-26-111321:0
2,037 shares@ US$35.780.0030% mcap1.3% of flowCommon StockSEC:0001193125-26-111330:0
21,129 shares@ US$5.9611.4% of flowCommon StockSEC:0001193125-26-106546:0
21,129 shares@ US$5.9631.7% of flowCommon StockSEC:0001193125-26-106544:0
7,811 shares0Common StockSEC:0001193125-26-104529:0
7,549 shares0Common StockSEC:0001193125-26-104526:0
25 of 231 declarations
About PERDOCEO EDUCATION Corp
Perdoceo Education Corporation (NYSE/NASDAQ: PRDO) is a U.S.-based postsecondary education company focused on career-oriented training and degree programs. Headquartered in Schaumburg, Illinois, United States, the company was incorporated in Delaware in 1994 under the name Career Education Corporation and adopted the Perdoceo name in 2020. Its model is that of a publicly traded private-education provider serving adult learners, working professionals, and, in parts of its portfolio, military-affiliated students.
Perdoceo currently operates several accredited academic institutions: Colorado Technical University (CTU), the American InterContinental University System (AIUS), and, since December 2, 2024, the University of St. Augustine for Health Sciences (USAHS). Across these schools, the company offers programs from the associate through doctoral level, as well as non-degree and professional-development offerings. Delivery is primarily online, with hybrid and campus-based formats depending on the institution. CTU’s curriculum is especially concentrated in business and management, nursing, healthcare management, computer science, engineering, information systems and technology, project management, cybersecurity, and criminal justice. AIUS is similarly aimed at adult learners seeking flexible, career-relevant education.
Read moreShow less
In the U.S. private higher-education landscape, Perdoceo stands out for a strategy centered on operational discipline, technology-enabled instruction, and selective capital allocation. The company emphasizes personalized learning tools such as intellipath®, alongside analytics and digital systems designed to improve student engagement, retention, and academic outcomes. The acquisition of USAHS materially expanded Perdoceo’s exposure to the healthcare education market, a structurally attractive segment supported by long-term demand for trained healthcare professionals.
Geographically, Perdoceo remains overwhelmingly U.S.-centric, with a nationwide reach through online enrollment and a limited campus footprint. That makes the company less dependent on one local market and more reliant on national student demand, retention trends, and regulatory conditions. For French-speaking investors, PRDO represents a relatively niche but meaningful education platform with a mix of defensive characteristics and execution risk typical of the sector.
Recent highlights include the company’s February 2026 release of full-year 2025 results, in which management cited solid operating momentum, strong prospective-student interest, and high retention across its institutions. In November 2025, Perdoceo also reported results ahead of expectations and noted continued investment in academics, student technology, and support processes, while returning capital through share repurchases and dividends. The completion of the USAHS acquisition in late 2024 remains the most important strategic development in the recent period.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
